liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Physicians' gender and specialty in relation to adverse drug reaction reporting in Sweden
Umeå Univ, Sweden.
Futurum Acad Healthcare, Sweden.
Med Prod Agcy, Sweden.
Med Prod Agcy, Sweden.
Show others and affiliations
2026 (English)In: European Journal of Clinical Pharmacology, ISSN 0031-6970, E-ISSN 1432-1041, Vol. 82, no 6, article id 146Article in journal (Refereed) Published
Abstract [en]

Purpose To evaluate the possible influence of gender and specialty on adverse drug reaction (ADR) reporting among physicians before and after the COVID-19 pandemic. Methods This retrospective nationwide register study analysed all ADR reports submitted by physicians to the Swedish Medical Products Agency during 2017 and 2023 (n = 4079 and 3740, respectively). The reporting rates were calculated and stratified by gender and specialty. Results The highest reporting rate among physicians was observed in medical specialties, followed by primary care and psychiatry (27, 10, and 12, reports/100 physicians in 2017; 18, 15, and 9 in 2023). The lowest reporting rates were observed for surgical and hospital service specialties (8 and 1 in 2017; 6 and 1 in 2023). Male and female physicians reported ADRs to a similar extent and both reported more frequently on female patients. Gender concordance between physician and patient was associated with significantly higher reporting (p < 0.001 in 2017; p = 0.041 in 2023). Conclusion Reporting varied across specialties, and gender concordance emerged as a previously unrecognized factor influencing ADR reporting. These findings provide new opportunities for targeted interventions to enhance physician participation in pharmacovigilance.

Place, publisher, year, edition, pages
SPRINGER HEIDELBERG , 2026. Vol. 82, no 6, article id 146
Keywords [en]
Pharmacovigilance; Adverse drug reaction reporting systems; Sex factors; Physician-patient relations; Specialties, medical; Physicians; Time factors; Gender concordance
National Category
Social and Clinical Pharmacy
Identifiers
URN: urn:nbn:se:liu:diva-224060DOI: 10.1007/s00228-026-04077-9ISI: 001759040400002PubMedID: 42098474Scopus ID: 2-s2.0-105038177136OAI: oai:DiVA.org:liu-224060DiVA, id: diva2:2060598
Note

Funding Agencies|Umea University

Available from: 2026-05-18 Created: 2026-05-18 Last updated: 2026-07-01

Open Access in DiVA

fulltext(758 kB)11 downloads
File information
File name FULLTEXT01.pdfFile size 758 kBChecksum SHA-512
e66d8e92da2c626fbea5fcd9407a9f36e9eaa6225635d3759b49f89c57f4addad3e071bf871ac9743df48599576b341ee14d982c1d7b5fa787573ea510e75730
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Hägg, Staffan
By organisation
Division of Clinical Chemistry and PharmacologyFaculty of Medicine and Health Sciences
In the same journal
European Journal of Clinical Pharmacology
Social and Clinical Pharmacy

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 16 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf